Ocular Implants Market Size to Grow by USD 1.82 Bn, Vendors to Deploy Organic and Inorganic Growth Strategies - Technavio
NEW YORK, Oct. 7, 2022 /PRNewswire/ -- The "Ocular Implants Market by Product (IOLs, corneal implants, glaucoma implants, and ocular prostheses) and Geography (North America, Europe, Asia, and Rest of World (ROW)) - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. The potential growth difference for the ocular implants market size between 2021 and 2026 is USD 1.82 billion. To get the exact yearly growth variance and the Y-O-Y growth rate, Request a FREE PDF Sample Report
Vendor Landscape
The ocular implants market is fragmented because of the presence of several global and regional vendors. Vendors are deploying organic and inorganic growth strategies to compete in the market. Global vendors have a strong foothold in the market, with a wide range of flagship products. These vendors are focusing on innovation and technological advances to remain competitive in terms of quality, brand, and reliability. In addition, they are strengthening their customer base by improving their product offerings and expanding their geographic reach. The competition in the global ocular implants market is expected to intensify, as new companies are coming up with innovative products.
Key Market Dynamics
The increasing prevalence of ophthalmic diseases is driving the ocular implants market growth. However, factors such as the high cost of premium ocular implants may challenge the market growth during the forecast period.
Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report
Market Segmentation
By product, the IOLs segment will be the largest contributor to market growth during the forecast period. The growth of this segment is attributed to factors such as the increasing focus of vendors on manufacturing innovative products. There are various types of IOLs in the market, such as foldable IOLs, silicone IOLs, single-piece IOLs, and three-piece IOLs. IOL implant surgeries are successful surgical procedures. Every year, more than 15 million IOLs are implanted globally. The reason for the rise in the number of these surgeries is the increasing aging population and the rising demand for high-quality vision care products.
By geography, North America will account for 36% of the market's growth during the forecast period. This growth is attributed to factors such as the rise in public healthcare expenditure. The US is the key country for the ocular implants market in North America. Moreover, market growth in this region will be faster than the growth of the market in ROW.
View our FREE PDF Sample Reportfor additional insights into the contribution of all the segments and regional opportunities in the report.
Some Companies Mentioned
AJL Ophthalmic SA
Bausch Health Companies Inc.
Becton Dickinson and Co.
Care Group Sight Solution Pvt. Ltd.
Carl Zeiss AG
CorNeat Vision Ltd
EyeD Pharma s.a.
F.AD. Muller Sohne GmbH and Co. KG
Glaukos Corp
Gulden Ophthalmics
HOYA Corp.
HumanOptics Holding AG
Johnson and Johnson
Morcher GmbH
NIDEK Co. Ltd
Novartis AG
Omni Lens Pvt Ltd
Ophtec BV
Rayner Intraocular Lenses Ltd.
Second Sight Medical Products Inc.
Want your report customized? Speak to an analyst and personalize your report according to your needs
Related Reports
Neuropathy Pain Treatment Market by Type and Geography - Forecast and Analysis 2022-2026: The neuropathy pain treatment market share is expected to increase by USD 3.81 billion from 2021 to 2026.
Rapid Diagnostics Market by Application and Geography - Forecast and Analysis 2022-2026: The rapid diagnostics market share is expected to increase by USD 12.74 billion from 2021 to 2026.
Ocular Implants Market Scope
Report Coverage
Details
Page number
120
Base year
2021
Forecast period
2022-2026
Growth momentum & CAGR
Accelerate at a CAGR of 7.26%
Market growth 2022-2026
USD 1.82 billion
Market structure
Fragmented
YoY growth (%)
6.34
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 36%
Key consumer countries
US, Germany, France, UK, and China
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
AJL Ophthalmic SA, Bausch Health Companies Inc., Becton Dickinson and Co., Care Group Sight Solution Pvt. Ltd., Carl Zeiss AG, CorNeat Vision Ltd, EyeD Pharma s.a., F.AD. Muller Sohne GmbH and Co. KG, Glaukos Corp, Gulden Ophthalmics, HOYA Corp., HumanOptics Holding AG, Johnson and Johnson, Morcher GmbH, NIDEK Co. Ltd, Novartis AG, Omni Lens Pvt Ltd, Ophtec BV, Rayner Intraocular Lenses Ltd., and Second Sight Medical Products Inc.
Market Dynamics
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Exhibit 43: Data Table on Ocular prostheses - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Product
Exhibit 44: Market opportunity by Product ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share by geography 2021-2026 (%)
Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 82: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 86: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 AJL Ophthalmic SA
Exhibit 93: AJL Ophthalmic SA - Overview
Exhibit 94: AJL Ophthalmic SA - Product / Service
Exhibit 95: AJL Ophthalmic SA - Key offerings
10.4 Bausch Health Companies Inc.
Exhibit 96: Bausch Health Companies Inc. - Overview
Exhibit 97: Bausch Health Companies Inc. - Business segments
Exhibit 98: Bausch Health Companies Inc. - Key news
Exhibit 99: Bausch Health Companies Inc. - Key offerings
Exhibit 100: Bausch Health Companies Inc. - Segment focus
10.5 Carl Zeiss AG
Exhibit 101: Carl Zeiss AG - Overview
Exhibit 102: Carl Zeiss AG - Business segments
Exhibit 103: Carl Zeiss AG - Key offerings
Exhibit 104: Carl Zeiss AG - Segment focus
10.6 EyeD Pharma s.a.
Exhibit 105: EyeD Pharma s.a. - Overview
Exhibit 106: EyeD Pharma s.a. - Product / Service
Exhibit 107: EyeD Pharma s.a. - Key offerings
10.7 Gulden Ophthalmics
Exhibit 108: Gulden Ophthalmics - Overview
Exhibit 109: Gulden Ophthalmics - Product / Service
Exhibit 110: Gulden Ophthalmics - Key offerings
10.8 Johnson and Johnson
Exhibit 111: Johnson and Johnson - Overview
Exhibit 112: Johnson and Johnson - Business segments
Exhibit 113: Johnson and Johnson - Key news
Exhibit 114: Johnson and Johnson - Key offerings
Exhibit 115: Johnson and Johnson - Segment focus
10.9 Morcher GmbH
Exhibit 116: Morcher GmbH - Overview
Exhibit 117: Morcher GmbH - Product / Service
Exhibit 118: Morcher GmbH - Key offerings
10.10 NIDEK Co. Ltd
Exhibit 119: NIDEK Co. Ltd - Overview
Exhibit 120: NIDEK Co. Ltd - Business segments
Exhibit 121: NIDEK Co. Ltd - Key news
Exhibit 122: NIDEK Co. Ltd - Key offerings
Exhibit 123: NIDEK Co. Ltd - Segment focus
10.11 Novartis AG
Exhibit 124: Novartis AG - Overview
Exhibit 125: Novartis AG - Business segments
Exhibit 126: Novartis AG - Key offerings
Exhibit 127: Novartis AG - Segment focus
10.12 Second Sight Medical Products Inc.
Exhibit 128: Second Sight Medical Products Inc. - Overview
Exhibit 129: Second Sight Medical Products Inc. - Product / Service
Exhibit 130: Second Sight Medical Products Inc. - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 131: Inclusions checklist
Exhibit 132: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 133: Currency conversion rates for US$
11.4 Research methodology
Exhibit 134: Research methodology
Exhibit 135: Validation techniques employed for market sizing
Exhibit 136: Information sources
11.5 List of abbreviations
Exhibit 137: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...
On Wednesday, April 17, the San Joaquin Valley Health Fund (SJVHF) launched "Equity on the Road" a multi-city series of community town halls to deepen local understanding of state issues and to advocate for more resources in the San Joaquin Valley....
The Honourable Mark Holland, Minister of Health, will host an event at the University of Waterloo to highlight the federal budget's investments to support students.
The Minister will be joined by Bryan May, Parliamentary Secretary to the Minister of...
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,...